Choosing the “right” treatment for a given patient involves a large number of factors, including personal preference—both the clinician’s and the patient’s. Is there a better way?

There’s a rich history of research suggesting that glutamate may be involved in the pathogenesis of schizophrenia, with an increasing amount of attention being brought to glutamate during the past decade or so.

We know how frequently our patients complain of anxiety. Anxiety disorders are common, chronic conditions. They also increase the risk for mood and substance disorders, and complaints of anxiety are found in a wide range of other psychiatric and medical conditions, as well.

Documents:  FDA-Approved Medications for Anxiety.pdf...